|
|
Volumn 82, Issue SUPPL. 1, 1999, Pages 14-18
|
|
Plasminogen activator inhibitor type-1 (PAI-1) and its role in cardiovascular disease
a
|
|
Author keywords
Arteriosclerosis; Atherogenesis; Endogenous fibrinolysis; Risk factor
|
|
Indexed keywords
1,3 BUTADIENE DERIVATIVE;
3 BENZYLIDENE 4 (3,4,5 TRIMETHOXYBENZYLIDENE)SUCCINIMIDE;
ANCROD;
ENDOTOXIN;
MONOCLONAL ANTIBODY;
PIPERAZINEDIONE;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
TISSUE PLASMINOGEN ACTIVATOR;
UNCLASSIFIED DRUG;
XR 5118;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CONFERENCE PAPER;
CORONARY ARTERY BYPASS GRAFT;
CORONARY ARTERY DILATATION;
EUROPE;
FIBRINOLYSIS;
GRAFT OCCLUSION;
HEART INFARCTION;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
JAPAN;
MAJOR CLINICAL STUDY;
MORTALITY;
NONHUMAN;
PATHOGENESIS;
PREDICTION;
PRIORITY JOURNAL;
RESTENOSIS;
RISK FACTOR;
SMOKING;
UNITED STATES;
|
|
EID: 0033376209
PISSN: 03406245
EISSN: None
Source Type: Journal
DOI: 10.1055/s-0037-1615546 Document Type: Conference Paper |
|
Times cited : (81)
|
|
References (58)
|
